- Home
- WHLR vs TOVX Comparison
WHLR vs TOVX Comparison
Compare WHLR & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- TOVX
- Stock Information
- Founded
- WHLR 2011
- TOVX 2001
- Country
- WHLR United States
- TOVX United States
- Employees
- WHLR N/A
- TOVX N/A
- Industry
- WHLR Real Estate Investment Trusts
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- TOVX Health Care
- Exchange
- WHLR Nasdaq
- TOVX Nasdaq
- Market Cap
- WHLR 4.2M
- TOVX 3.8M
- IPO Year
- WHLR 2012
- TOVX 2006
- Fundamental
- Price
- WHLR $4.90
- TOVX $0.48
- Analyst Decision
- WHLR
- TOVX Hold
- Analyst Count
- WHLR 0
- TOVX 1
- Target Price
- WHLR N/A
- TOVX N/A
- AVG Volume (30 Days)
- WHLR 719.6K
- TOVX 608.6K
- Earning Date
- WHLR 11-06-2025
- TOVX 11-11-2025
- Dividend Yield
- WHLR N/A
- TOVX N/A
- EPS Growth
- WHLR N/A
- TOVX N/A
- EPS
- WHLR N/A
- TOVX N/A
- Revenue
- WHLR $102,799,000.00
- TOVX N/A
- Revenue This Year
- WHLR N/A
- TOVX N/A
- Revenue Next Year
- WHLR N/A
- TOVX N/A
- P/E Ratio
- WHLR N/A
- TOVX N/A
- Revenue Growth
- WHLR N/A
- TOVX N/A
- 52 Week Low
- WHLR $4.74
- TOVX $0.37
- 52 Week High
- WHLR $22,400.00
- TOVX $2.64
- Technical
- Relative Strength Index (RSI)
- WHLR 53.21
- TOVX 66.51
- Support Level
- WHLR $5.35
- TOVX $0.39
- Resistance Level
- WHLR $6.13
- TOVX $0.43
- Average True Range (ATR)
- WHLR 0.53
- TOVX 0.03
- MACD
- WHLR -0.03
- TOVX 0.01
- Stochastic Oscillator
- WHLR 58.15
- TOVX 84.72
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.